Rituxirel 100mg Rituximab Injection Trade Information
Australia Middle East South America Asia North America Africa Western Europe Central America Eastern Europe
All India
Product Description
The Rituxirel 100mg Rituximab Injection is made available by us that is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. At present, Rituximab is the most important mAb of clinical value in patients with B-cell lymphoid malignancies. It is used in the treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), granulomatosis with polyangiitis and microscopic polyangiitis. It is a type of medication called a monoclonal antibody. It works by attaching to certain blood cells from your immune system (B cells) and killing them. Rituxirel 100mg Rituximab Injection is very useful.